These findings provide further insights into the regulatory relationship between the G2019S mutation, THBS1, and TGF‐β1, highlighting a potential mechanism through which LRRK2 may modulate TGF‐β signaling in the context of PD. The gene discussed is THBS1; the disease is Parkinson disease.